FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076350025> ?p ?o ?g. }

• W2076350025 endingPage "1339" @default.
• W2076350025 startingPage "1333" @default.
• W2076350025 abstract "While observational studies have suggested that unopposed estrogens reduce the incidence of coronary disease in postmenopausal women, there are few data on the effect of combined therapy with estrogens and progestins--a regimen adopted in recent years to minimize the risk of endometrial hyperplasia and cancer. In clinical trials, the addition of progestins has an adverse effect on serum lipid levels, and these lipid effects have raised the question of whether combined estrogen-progestin therapy increases the risk of coronary disease compared with the use of estrogen alone.We conducted a population-based, case-control study among enrollees of Group Health Cooperative of Puget Sound. Cases were postmenopausal women who sustained an incident fatal or nonfatal myocardial infarction in 1986 through 1990. Controls were a stratified random sample of female Group Health Cooperative enrollees frequency matched to the cases by age and calendar year. We reviewed the medical records of the 502 cases and 1193 controls and conducted brief telephone interviews with consenting survivors. The health maintenance organization's computerized pharmacy database was used to ascertain the use of postmenopausal hormones. For the primary analysis of current use, we classified women into one of three groups: (1) nonusers of hormones; (2) users of estrogens alone; or (3) users of combined therapy including both estrogens and progestins. Each group of hormone users was compared with nonusers.After adjustment for potential confounding factors, the risk ratio of myocardial infarction associated with current use of estrogens alone was 0.69 (95% confidence interval, 0.47 to 1.02); and the risk ratio of myocardial infarction associated with current use of combined therapy was 0.68 (95% confidence interval, 0.38 to 1.22). Duration of combined-therapy use was relatively short, averaging less than 2 years in cases and controls.In this case-control study, the reduced risk of myocardial infarction associated with the use of estrogens alone was consistent with previous observational studies. Although the 95% confidence interval only excluded a risk above 1.22, the current use of combined therapy was not associated with an adverse effect on the incidence of myocardial infarction in postmenopausal women." @default.
• W2076350025 created "2016-06-24" @default.
• W2076350025 creator A5002821639 @default.
• W2076350025 creator A5006663312 @default.
• W2076350025 creator A5006666563 @default.
• W2076350025 creator A5009270847 @default.
• W2076350025 creator A5017572190 @default.
• W2076350025 creator A5032399461 @default.
• W2076350025 creator A5035299028 @default.
• W2076350025 creator A5062960594 @default.
• W2076350025 date "1994-06-27" @default.
• W2076350025 modified "2023-10-01" @default.
• W2076350025 title "The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women" @default.
• W2076350025 cites W1480965804 @default.
• W2076350025 cites W1932760451 @default.
• W2076350025 cites W1982184446 @default.
• W2076350025 cites W1987144846 @default.
• W2076350025 cites W1994185207 @default.
• W2076350025 cites W1997967664 @default.
• W2076350025 cites W2044769150 @default.
• W2076350025 cites W2046800613 @default.
• W2076350025 cites W2063031738 @default.
• W2076350025 cites W2069883047 @default.
• W2076350025 cites W2072040768 @default.
• W2076350025 cites W2094643903 @default.
• W2076350025 cites W2120955256 @default.
• W2076350025 cites W2142759485 @default.
• W2076350025 cites W2143015087 @default.
• W2076350025 cites W2150577849 @default.
• W2076350025 cites W2161197885 @default.
• W2076350025 cites W2169071913 @default.
• W2076350025 cites W2314604683 @default.
• W2076350025 cites W2338124628 @default.
• W2076350025 cites W2403318671 @default.
• W2076350025 cites W2517346518 @default.
• W2076350025 doi "https://doi.org/10.1001/archinte.154.12.1333" @default.
• W2076350025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8002685" @default.
• W2076350025 hasPublicationYear "1994" @default.
• W2076350025 type Work @default.
• W2076350025 sameAs 2076350025 @default.
• W2076350025 citedByCount "157" @default.
• W2076350025 countsByYear W20763500252012 @default.
• W2076350025 countsByYear W20763500252014 @default.
• W2076350025 countsByYear W20763500252015 @default.
• W2076350025 countsByYear W20763500252016 @default.
• W2076350025 countsByYear W20763500252017 @default.
• W2076350025 countsByYear W20763500252018 @default.
• W2076350025 countsByYear W20763500252023 @default.
• W2076350025 crossrefType "journal-article" @default.
• W2076350025 hasAuthorship W2076350025A5002821639 @default.
• W2076350025 hasAuthorship W2076350025A5006663312 @default.
• W2076350025 hasAuthorship W2076350025A5006666563 @default.
• W2076350025 hasAuthorship W2076350025A5009270847 @default.
• W2076350025 hasAuthorship W2076350025A5017572190 @default.
• W2076350025 hasAuthorship W2076350025A5032399461 @default.
• W2076350025 hasAuthorship W2076350025A5035299028 @default.
• W2076350025 hasAuthorship W2076350025A5062960594 @default.
• W2076350025 hasConcept C121608353 @default.
• W2076350025 hasConcept C126322002 @default.
• W2076350025 hasConcept C2776607906 @default.
• W2076350025 hasConcept C2777088508 @default.
• W2076350025 hasConcept C2777164284 @default.
• W2076350025 hasConcept C2778562196 @default.
• W2076350025 hasConcept C2780275930 @default.
• W2076350025 hasConcept C2781413609 @default.
• W2076350025 hasConcept C2908647359 @default.
• W2076350025 hasConcept C29456083 @default.
• W2076350025 hasConcept C44249647 @default.
• W2076350025 hasConcept C500558357 @default.
• W2076350025 hasConcept C530470458 @default.
• W2076350025 hasConcept C71924100 @default.
• W2076350025 hasConcept C77350462 @default.
• W2076350025 hasConcept C99454951 @default.
• W2076350025 hasConceptScore W2076350025C121608353 @default.
• W2076350025 hasConceptScore W2076350025C126322002 @default.
• W2076350025 hasConceptScore W2076350025C2776607906 @default.
• W2076350025 hasConceptScore W2076350025C2777088508 @default.
• W2076350025 hasConceptScore W2076350025C2777164284 @default.
• W2076350025 hasConceptScore W2076350025C2778562196 @default.
• W2076350025 hasConceptScore W2076350025C2780275930 @default.
• W2076350025 hasConceptScore W2076350025C2781413609 @default.
• W2076350025 hasConceptScore W2076350025C2908647359 @default.
• W2076350025 hasConceptScore W2076350025C29456083 @default.
• W2076350025 hasConceptScore W2076350025C44249647 @default.
• W2076350025 hasConceptScore W2076350025C500558357 @default.
• W2076350025 hasConceptScore W2076350025C530470458 @default.
• W2076350025 hasConceptScore W2076350025C71924100 @default.
• W2076350025 hasConceptScore W2076350025C77350462 @default.
• W2076350025 hasConceptScore W2076350025C99454951 @default.
• W2076350025 hasIssue "12" @default.
• W2076350025 hasLocation W20763500251 @default.
• W2076350025 hasLocation W20763500252 @default.
• W2076350025 hasOpenAccess W2076350025 @default.
• W2076350025 hasPrimaryLocation W20763500251 @default.
• W2076350025 hasRelatedWork W1725742191 @default.
• W2076350025 hasRelatedWork W1967719934 @default.
• W2076350025 hasRelatedWork W1976389358 @default.
• W2076350025 hasRelatedWork W1992146546 @default.

• next